Our Children With Type 1 Diabetes: Causes, Solutions, and a New Prognosis

In this post, Carla Atherton, Director of the Healthy Family Formula, relates how she discovered that functional medicine has better answers for why her daughter developed type 1 diabetes.

What Are We Missing in Conventional Care for Type 1 Diabetes?

When I got the call from the doctor that fateful day, (February 2nd, 2012, to be exact), our lives changed forever. “Carla,” she said, “your daughter has diabetes.” I stood in my friend’s entrance with my silver flip phone in my hand while my three children bustled around me getting their boots and jackets on to go home. But we weren’t going home. We were going to the hospital.

When we arrived in the hospital, we trusted the staff to tell us what to do, but it didn’t take long before I realized that our goals and theirs were much different, that they had no answers for us, only a “hush, darling, don’t ask too much,” in response to my questions which later escalated to demands.

Seven years later, I have finally learned all that I should have been taught then, all that I should have been taught all my life, really. The true answers to: “what happened?” and “why?” and “where do we go from here?”

What Causes Type 1 Diabetes?

My goals were not to limp my daughter along with disempowering complacency, short-sighted, impotent goals, and substandard care and not to head to the hospital whenever things hit critical mass. They were to find out what caused my daughter’s illness and then to help her to recover from it in every way: mind, spirit, and body. Instinctually, I knew that there was more to this health thing than what I had ever been taught.

And then I found functional medicine. The science and research, the upgraded and integrative health paradigm together matched what my mama instinct, my scientist brain, my poet heart all knew was right: there was more, much more, for her.

As a mother seven years into this journey with my own daughter AND as a family health professional, I can tell you that much about what we are taught about type 1 diabetes through conventional medicine is only part of the story, and in some cases, it’s not even the story at all.

I discovered that there are many factors that all play significant roles in the onset and perpetuation of type 1 diabetes:

  • Functional assessments
  • Environmental causal factors
  • Infections causal factors
  • Lifestyle factors
  • The connection to the central nervous system

And they all hold keys to the vault of wellness battened down with many heavy chains.

A Functional, Holistic Approach to Type 1 Diabetes

When we don’t take a functional, holistic approach, we miss the opportunity to open up an entire world of possibilities. Did you know that:

  • Intestinal permeability is one of the triad of causal factors for autoimmunity?
  • Many children who have type 1 diabetes also have celiac disease, many of whom are undiagnosed?
  • Type 1 diabetes can be linked to:
    • Hemochromatosis (a typically genetic condition in which excess iron is not eliminated from the body)
    • Toxicity/injury from routine medical childhood procedures
    • A sensitivity to milk (specifically the peptide casein A1-b)

There ARE causes for the onset of type 1 diabetes (not just bad luck), and type 1 can be prevented for our other children.

The Role of the Central Nervous System

The central nervous system plays an integral role in the onset and perpetuation of type 1 diabetes. In type 1 diabetes, the body doesn’t produce insulin, and this allows blood sugar levels to reach dangerously high levels. Therapies that calm the central nervous system such as craniosacral therapy, photobiomodulation, aromatherapy, and acupressure can significantly reduce blood sugar levels.

On the flip side, emotional stressors and environmental stressors such as WiFi can significantly increase blood sugar levels. Controlling blood sugar is not just a numbers game, but contingent on a myriad of chemical, hormonal, nutritional, viral, emotional, environmental, and bacterial factors.

How to Get Off the Blood Sugar Rollercoaster

My concern is this: what are parents like me not being taught about diet, exercise, rest, environment, causes, solutions, treatments, recovery, and future health outcomes? Parents are more than ready to get off of the emotional and physical rollercoaster of chronic illness and to help their children take charge of their health so they can get on with the business of living.

In this series of articles, I will tell you all I know about NOT simply managing type 1 diabetes but transcending the diagnosis. As a holistic family health consultant and mother of a daughter with type 1 diabetes, I have a lot to share with you about a new way to view type 1 diabetes and how to help your children:

  • Stabilize blood sugar
  • Feel better and more healthy on a daily basis
  • Minimize or eliminate hospital visits and emergencies
  • Prevent co-morbitidities and further health complications

You can and should be empowered to create your own child’s healing plan so your family can move beyond the diagnosis.

To read Carla’s series of articles about causes, solutions, and a new prognosis for your child with type 1 diabetes, check out her article about it here.

About Carla Atherton MA FDN-P

Carla Atherton, MA, FDN-P, Family Health Coach, is the director of The Healthy Family Formula, host of The Children’s and Teen Health Summit, author of Family Health Revolution, editor, book junkie and research geek.  She is the insatiably curious mother of three grown (son age 20), almost grown (daughter age 18), and growing (daughter age 15) children, one of whom has type 1 diabetes.

Carla lives on an acreage in rural Saskatchewan, Canada, where she works from a home office with families from all over the world on the reversal of children’s chronic health conditions. Carla is on a revolutionary mission to empower families to transcend our new normal of ill health and chronic disease. You can find out more about her and her work at her website https://healthyfamilyformula.com/

Carla Atherton

Still Looking for Answers?

Visit the Epidemic Answers Practitioner Directory to find a practitioner near you.

Join us inside our online membership community for parents, Healing Together, where you’ll find even more healing resources, expert guidance, and a community to support you every step of your child’s healing journey.

Sources & References

Accurso, A., et al. Dietary carbohydrate restriction in type 2 diabetes mellitus and metabolic syndrome: time for a critical appraisal. Nutr Metab (Lond). 2008 Apr 8:5:9.

Acuña-Catalán, D., et al. Ketogenic diet administration later in life improves memory by modifying the synaptic cortical proteome via the PKA signaling pathway in aging mice. Cell Rep Med. 2024 Jun 18;5(6):101593.

Adebayo, O., et al. The changing face of diabetes in America. Emerg Med Clin North Am. 2014;32(2):319-27.

Aggarwal, B.B., et al. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol. 2006 May 14;71(10):1397-421.

Allen, B.G., et al. Ketogenic diets as an adjuvant cancer therapy: History and potential mechanism. Redox Biol. 2014:2:963-70.

Anand, P., et al. Cancer is a preventable disease that requires major lifestyle changes. Pharm Res. 2008 Sep;25(9):2097-116.

Aucoin, M., et al. Generalized anxiety disorder and hypoglycemia symptoms improved with diet modificationCase Rep Psychiatry. 2016;2016.

Bădescu, S.V., et al. The association between Diabetes mellitus and Depression. J Med Life. 2016 Apr-Jun; 9(2): 120–125.

Bahr, L.S., et al. Ketogenic diet and fasting diet as Nutritional Approaches in Multiple Sclerosis (NAMS): protocol of a randomized controlled study. Trials. 2020 Jan 2;21(1):3.

Banerjee, S., et al. Ayurveda in changing scenario of diabetes management for developing safe and effective treatment choices for the future. J Complement Integr Med. 2015.

Basic, M., et al. Obesity: genome and environment interactions. Arh Hig Rada Toksikol. 2012;63(3):395-405.

Bernstein, R.K. Blood glucose self-monitoring by diabetic patients: refinements of procedural technique. Diabetes Care. 1979 Mar-Apr;2(2):233-6.

Bernstein, R.K. Virtually continuous euglycemia for 5 yr in a labile juvenile-onset diabetic patient under noninvasive closed-loop control. Diabetes Care. 1980 Jan-Feb;3(1):140-3.

Bipartisan Policy Center. Lots to lose how America’s health and obesity crisis threatens our economic future. Washington, D.C.: Bipartisan Policy Center,; 2012.

Boison, D. New insights into the mechanisms of the ketogenic diet. Curr Opin Neurol. 2017 Apr;30(2):187-192.

Bostock, E.C.S., et al. The Current Status of the Ketogenic Diet in Psychiatry. Front Psychiatry. 2017 Mar 20:8:43.

Bradford, B.L., et al. Mitochondrial Dysfunction and Type 2 Diabetes. Science. 2005 Jan 21;307(5708):384-7.

Brenton, J.N., et al. Phase II study of ketogenic diets in relapsing multiple sclerosis: safety, tolerability and potential clinical benefits. J Neurol Neurosurg Psychiatry. 2022 Jun;93(6):637-644.

Brenton, J.N., et al. Pilot study of a ketogenic diet in relapsing-remitting MS. Neurol Neuroimmunol Neuroinflamm. 2019 Apr 12;6(4):e565.

Carlson, J.A., et al. Dietary-related and physical activity-related predictors of obesity in children: a 2-year prospective study. Child Obes. 2012;8(2):110-5.

Centers for Disease Control and Prevention. All About Your A1C.

Centers for Disease Control and Prevention. Diabetes Tests.

Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2020: Estimates of Diabetes and Its Burden in the United States.

Cheng, N., et al. Metabolic Dysfunction Underlying Autism Spectrum Disorder and Potential Treatment Approaches. Front Mol Neurosci. 2017 Feb 21:10:34.

Choquet, H., et al. Genomic insights into early-onset obesity. Genome Med. 2010;2(6):36.

Classen, J.B. Review of evidence that epidemics of type 1 diabetes and type 2 diabetes/metabolic syndrome are polar opposite responses to iatrogenic inflammation. Curr Diabetes Rev. 2012;8(6):413-8.

Coller, H.A. Is cancer a metabolic disease? Am J Pathol. 2014 Jan;184(1):4-17.

Cortese, S., et al. Attention-deficit/hyperactivity disorder, iron deficiency, and obesity: is there a link? Postgrad Med. 2014;126(4):155-70.

Cui, J., et al. Butyrate-Producing Bacteria and Insulin Homeostasis: The Microbiome and Insulin Longitudinal Evaluation Study (MILES). Diabetes. 2022 Nov 1;71(11):2438-2446.

Danan, K., et al. The Ketogenic Diet for Refractory Mental Illness: A Retrospective Analysis of 31 Inpatients. Front Psychiatry. 2022 Jul 6:13:951376.

deCampo, D.M., et al. Ketogenic dietary therapies for epilepsy and beyond. Curr Opin Clin Nutr Metab Care. 2019 Jul;22(4):264-268.

de la Rubia Orti, J.E., et al. Can Ketogenic Diet Improve Alzheimer’s Disease? Association With Anxiety, Depression, and Glutamate System. Front Nutr. 2021 Oct 27:8:744398.

de la Rubia Orti, J.E., et al. Exploring the impact of ketogenic diet on multiple sclerosis: obesity, anxiety, depression, and the glutamate system. Front Nutr. 2023 Aug 25:10:1227431.

Desai, J.R., et al. Diabetes and asthma case identification, validation, and representativeness when using electronic health data to construct registries for comparative effectiveness and epidemiologic research. Med Care. 2012;50 Suppl:S30-5.

Dietch, D.M., et al. Efficacy of low carbohydrate and ketogenic diets in treating mood and anxiety disorders: systematic review and implications for clinical practice. BJPsych Open. 2023 Apr 17;9(3):e70.

Duan, W., et al. Hyperglycemia, a neglected factor during cancer progression. Biomed Res Int. 2014:2014:461917.

Dyńka, D., et al. The Role of Ketogenic Diet in the Treatment of Neurological Diseases. Nutrients. 2022 Nov 24;14(23):5003.

Feinman, R.K., et al. Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base. Nutrition. 2015 Jan;31(1):1-13.

Giovannucci, E., et al. Diabetes and cancer: a consensus report. Diabetes Care. 2010 Jul;33(7):1674-85.

Gough, S., et al. Neuroprotection by the Ketogenic Diet: Evidence and Controversies. Front Nutr. 2021 Nov 23:8:782657.

Grammes, J., et al. Fear of hypoglycemia in patients with type 2 diabetes: The role of interoceptive accuracy and prior episodes of hypoglycemia. J Psychosom Res. 2018;105:58-63.

Grochowska, K., et al. The Effect of the Ketogenic Diet on the Therapy of Neurodegenerative Diseases and Its Impact on Improving Cognitive Functions. Dement Geriatr Cogn Dis Extra. 2022 May 30;12(2):100-106.

Hao, J., et al. Mitochondrial nutrients improve immune dysfunction in the type 2 diabetic Goto-Kakizaki rats. J Cell Mol Med. 2009 Apr;13(4):701-11.

He, C., et al. Targeting gut microbiota as a possible therapy for diabetes. Nutr Res. 2015.

Hinzmann, R., et al. What do we need beyond hemoglobin A1c to get the complete picture of glycemia in people with diabetes? Int J Med Sci. 2012;9(8):665-81.

Irish, A.K., et al. Randomized control trial evaluation of a modified Paleolithic dietary intervention in the treatment of relapsing-remitting multiple sclerosis: a pilot study. Degener Neurol Neuromuscul Dis. 2017 Jan 4;7:1-18.

Jiang, Z., et al. Effects of Ketogenic Diet on Neuroinflammation in Neurodegenerative Diseases. Aging Dis. 2022 Jul 11;13(4):1146-1165.

Kamba, A., et al. Association between higher serum cortisol levels and decreased insulin secretion in a general populationPLOS ONE. 2016;11(11):e0166077.

Kapoor, D., et al. Emerging Role of the Ketogenic Dietary Therapies beyond Epilepsy in Child Neurology. Ann Indian Acad Neurol. 2021 Jul-Aug;24(4):470-480.

Karkafi, R.E., et al. Ketogenic Diet and Inflammation: Implications for Mood and Anxiety Disorders. Adv Exp Med Biol. 2023:1411:537-554.

Kogut, S.J., et al. Evaluation of a program to improve diabetes care through intensified care management activities and diabetes medication copayment reduction. J Manag Care Pharm. 2012;18(4):297-310.

Kong., A.P, et al. Diabetes and its comorbidities–where East meets West. Nat Rev Endocrinol. 2013;9(9):537-47.

Labbé, D.P., et al. Role of diet in prostate cancer: the epigenetic link. Oncogene. 2015 Sep 3;34(36):4683-91.

Laron, Z. Interplay between heredity and environment in the recent explosion of type 1 childhood diabetes mellitus. Am J Med Genet. 2002;115(1):4-7.

Lee, C., et al. Reduced levels of IGF-I mediate differential protection of normal and cancer cells in response to fasting and improve chemotherapeutic index. Cancer Res. 2010 Feb 15;70(4):1564-72.

Lee, R.W.Y., et al. A modified ketogenic gluten-free diet with MCT improves behavior in children with autism spectrum disorder. Physiol Behav. 2018 May 1:188:205-211.

Lefevre, F., et al. Ketogenic diet for the treatment of refractory epilepsy in children: A systematic review of efficacy. Pediatrics. 2000 Apr;105(4):E46.

Lennerz, B.S., et al. Management of Type 1 Diabetes With a Very Low-Carbohydrate Diet.
Pediatrics. 2018 Jun;141(6):e20173349.

Levi, J., et al. F as in fat how obesity threatens America’s future : 2012. Washington, D.C.: Trust for America’s Health; 2012.

Li, Q., et al. A Ketogenic Diet and the Treatment of Autism Spectrum Disorder. Front Pediatr. 2021 May 11:9:650624.

Liu, H., et al. Refined fructose and cancer. Expert Opin Ther Targets. 2011 Sep;15(9):1049-59.

Lorenzi, M., et al. High glucose induces DNA damage in cultured human endothelial cells. J Clin Invest. 1986 Jan;77(1):322-5.

Ly, N.P., et al. Gut microbiota, probiotics, and vitamin D: interrelated exposures influencing allergy, asthma, and obesity? J Allergy Clin Immunol. 2011;127(5):1087-94; quiz 95-6.

Magrone, T., et al. Childhood obesity: immune response and nutritional approaches. Front Immunol. 2015;6:76.

Mentzelou, M., et al. The Relationship of Ketogenic Diet with Neurodegenerative and Psychiatric Diseases: A Scoping Review from Basic Research to Clinical Practice. Nutrients. 2023 May 11;15(10):2270.

Mierau, S.B., et al. Metabolic interventions in Autism Spectrum Disorder. Neurobiol Dis. 2019 Dec:132:104544.

Mu, C., et al. Metabolic Framework for the Improvement of Autism Spectrum Disorders by a Modified Ketogenic Diet: A Pilot Study. J Proteome Res. 2020 Jan 3;19(1):382-390.

Noland, R.C., et al. Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control. J Biol Chem. 2009 Aug 21;284(34):22840-52.

Olivito, I., et al. Ketogenic diet ameliorates autism spectrum disorders-like behaviors via reduced inflammatory factors and microbiota remodeling in BTBR T+ Itpr3tf/J mice. Exp Neurol. 2023 Aug:366:114432.

Onodera, Y., et al. Increased sugar uptake promotes oncogenesis via EPAC/RAP1 and O-GlcNAc pathways. J Clin Invest. 2014 Jan;124(1):367-84.

Operta, F.F., et al. The Ketogenic Diet for the Treatment of Mood Disorders in Comorbidity With Epilepsy in Children and Adolescents. Front Pharmacol. 2020 Nov 24:11:578396.

Pacal, L., et al. Parameters of oxidative stress, DNA damage and DNA repair in type 1 and type 2 diabetes mellitus. Arch Physiol Biochem. 2011;117(4):222-30.

Pietrzak, D., et al. The Therapeutic Role of Ketogenic Diet in Neurological Disorders. Nutrients. 2022 May 6;14(9):1952.

Power, R.A., et al. Carnitine revisited: potential use as adjunctive treatment in diabetes. Diabetologia. 2007 Apr;50(4):824-32.

Pulgaron, E.R. Childhood obesity: a review of increased risk for physical and psychological comorbidities. Clin Ther. 2013;35(1):A18-32.

Pulsifer, M.B., et al. Effects of ketogenic diet on development and behavior: preliminary report of a prospective study. Dev Med Child Neurol. 2001 May;43(5):301-6.

Rector, R.S., et al. Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model. J Hepatol. 2010 May;52(5):727-36.

Renteria, I., et al. [Factors affecting oxidative damage in obese children: an exploratory study]. Nutr Hosp. 2015;31(4):1499-503.

Rosa, J.S., et al. Altered inflammatory, oxidative, and metabolic responses to exercise in pediatric obesity and type 1 diabetes. Pediatr Diabetes. 2011;12(5):464-72.

Salzer, H.M. Relative hypoglycemia as a cause of neuropsychiatric illness. J Natl Med Assoc. 1966;58(1):12-17.

Sanchez, M., et al. Childhood obesity: a role for gut microbiota? Int J Environ Res Public Health. 2015;12(1):162-75. J Integr Complement Med. 2023 Feb;29(2):69-79.

Sanago, F., et al. Mind- and Body-Based Interventions Improve Glycemic Control in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis. J Integr Complement Med. 2023 Feb;29(2):69-79.

Seyfried, T.N. Cancer as a metabolic disease. Nutr Metab (Lond). 2010 Jan 27:7:7.

Seyfried, T.N. Cancer as a metabolic disease: implications for novel therapeutics. Carcinogenesis. 2014 Mar;35(3):515-27.

Seyfried, T.N., et al. Consideration of Ketogenic Metabolic Therapy as a Complementary or Alternative Approach for Managing Breast Cancer. Front Nutr. 2020 Mar 11:7:21.

Seyfried, T.N., et al. Is the restricted ketogenic diet a viable alternative to the standard of care for managing malignant brain cancer? Epilepsy Res. 2012 Jul;100(3):310-26.

Seyfried, T.N., et al. Metabolic management of brain cancer. Biochim Biophys Acta. 2011 Jun;1807(6):577-94.

Shen, W., et al. Protective effects of R-alpha-lipoic acid and acetyl-L-carnitine in MIN6 and isolated rat islet cells chronically exposed to oleic acid. J Cell Biochem. 2008 Jul 1;104(4):1232-43.

Shlomowitz, A., et al. Anxiety associated with self monitoring of capillary blood glucoseBritish Journal of Diabetes. 2014;14(2):60-63.

Smith, J., et al. Ketogenic diet restores aberrant cortical motor maps and excitation-to-inhibition imbalance in the BTBR mouse model of autism spectrum disorder. Behav Brain Res. 2016 May 1:304:67-70.

Smith, K.J., et al. Association of diabetes with anxiety: a systematic review and meta-analysisJ Psychosom Res. 2013;74(2):89-99.

Sreekumar, R., et al. Skeletal muscle mitochondrial dysfunction & diabetes. Indian J Med Res. 2007 Mar;125(3):399-410.

Stafstrom, C.E., et al. The ketogenic diet as a treatment paradigm for diverse neurological disorders. Front Pharmacol. 2012 Apr 9:3:59.

Tao, Y., et al. Ketogenic Diet: An Effective Treatment Approach for Neurodegenerative Diseases. Curr Neuropharmacol. 2022 Nov 15;20(12):2303-2319.

Tidman, M.M., et al. Effects of an low carbohydrate/healthy fat/ketogenic diet on biomarkers of health and symptoms, anxiety and depression in Parkinson's disease: a pilot study. Neurodegener Dis Manag. 2022 Apr;12(2):57-66.

Tinkum, K.L., et al. Fasting protects mice from lethal DNA damage by promoting small intestinal epithelial stem cell survival. Proc Natl Acad Sci U S A. 2015 Dec 22;112(51):E7148-54.

Tuomi, T., et al. The many faces of diabetes: a disease with increasing heterogeneity. Lancet. 2014;383(9922):1084-94.

Vaarala, O. Is the origin of type 1 diabetes in the gut? Immunol Cell Biol. 2012;90(3):271-6.

Vaarala, O. Gut microbiota and type 1 diabetes. Rev Diabet Stud. 2012;9(4):251-9.

Vargas, D.D., et al. Effectiveness of nutritional interventions on behavioral symptomatology of autism spectrum disorder: a systematic review. Nutr Hosp. 2022 Dec 20;39(6):1378-1388.

Verberne, A.J.M., et al. Adrenaline: insights into its metabolic roles in hypoglycaemia and diabetesBr J Pharmacol. 2016;173(9):1425-1437.

Witkowski, M., et al. The artificial sweetener erythritol and cardiovascular event risk. Nat Med. 2023 Mar;29(3):710-718.

Yuan, J., et al. Regular use of proton pump inhibitors and risk of type 2 diabetes: results from three prospective cohort studies. Gut. 28 Sep 2020.